Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|June 12, 2019
Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancerWhitney P Kirschbrown, Bei Wang, Ihsan Nijem, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2025
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysisAlberto Giovanni Leone, Fausto Petrelli, Samuel J Klempner, et al.
JAMA Oncology|December 6, 2016
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical TrialManish A Shah, Yung-Jue Bang, Florian Lordick, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2016
Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial)Russell Petty, Alan Anthoney, Jean-Philippe Metges, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 12, 2025
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)Maria Alsina Maqueda, Ana Teijo Quintáns, Miriam Cuatrecasas, et al.
Cancer Treatment Reviews|February 11, 2025
How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task forceChristelle de la Fouchardière, Antonella Cammarota, Magali Svrcek, et al.
British Journal of Cancer|August 24, 2021
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer groupThibaud Koessler, Maria Alsina, Dirk Arnold, et al.
Cancer Treatment Reviews|November 4, 2025
Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapyXuesong Zhao, Qianyun Hao, Maria Alsina, et al.
Clinical Colorectal Cancer|May 31, 2022
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer groupFrancesco Sclafani, Elisa Fontana, Lucjan Wyrwicz, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 8, 2022
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)Kohei Shitara, Toshihiko Doi, Hisashi Hosaka, et al.
Pageof 8